Options Trading News

August 30, 2013  Fri 3:39 AM CT


Traders are sticking with Nektar Therapeutics as the drug developer consolidates at multiyear highs.

optionMONSTER's Heat Seeker monitoring system detected the purchase of 7,500 October 12 calls for $1.80. A matching number of September 12 calls was sold at the same time for $1.20 against previous open interest.

We cited the buying in the September contracts earlier this month for $1.25 to $1.35, and yesterday's transaction allowed them to extend that bet position by one month at a cost of $0.60. See our Education Section for more on how to manage trades more effectively with options.

NKTR rose 3.05 percent to $12.16 yesterday, and has roughly doubled since late November. The company has a wide array of potential medicines under development, including at least five in late-stage trials. It's spent the last two months consolidating at levels last seen in early 2011.

Total option volume was 19 times greater than average in Wednesday's session, with calls outnumbering puts by a bullish 33-to-1 ratio.

Share this article with your friends



The fastest money in the market
View full report »

Premium Services

Education & Strategy

The art of trading

As I stated in last week's article, a break out or a break down needs to have a couple things happen before it is considered a confirmed break out or break down. The only problem is that in today's market where things move much more quicker than they did just a few years ago, two days could wind up being the majority of the expected movement, if not the whole movement.

View more education articles »